Prognosis is poor.
Angiosarcomas are very rare and aggressive cancers that spread early.
70% of patients die within 5 years of diagnosis. The tumors are made out of newly-formed blood vessels and stimulated to grow by vegf. New biologic therapies, called monoclonal antibodies, are being developed to target these cancerous blood vessels. Not much is know about these tumors due to their rarity.